Fiscal Nepal
First Business News Portal in English from Nepal
KATHMANDU: The Department of Drug Administration (DoA) has given approval to the use of covishield vaccine against COVID-19 in Nepal.
The covishield vaccine is developed by Serum Institute of India.
“Conditional permission has been granted for emergency use authorization of covishield vaccine against COVID-19 as per the decision of the department,” reads a press statement issued by DoA) today.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
